Option Care Health (NASDAQ:OPCH) Earns “Outperform” Rating from Barrington Research

Barrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH) in a research report report published on Wednesday, Benzinga reports. Barrington Research currently has a $40.00 price target on the stock.

Separately, JMP Securities lifted their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th.

Option Care Health Stock Performance

OPCH opened at $29.45 on Wednesday. The firm has a market cap of $5.12 billion, a P/E ratio of 19.38, a PEG ratio of 2.31 and a beta of 1.29. Option Care Health has a 1-year low of $26.11 and a 1-year high of $34.63. The company has a 50 day simple moving average of $31.00 and a two-hundred day simple moving average of $30.08. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.76 and a quick ratio of 1.36.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.03. The company had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. Option Care Health’s quarterly revenue was up 14.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.63 EPS. Equities analysts forecast that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Several hedge funds have recently made changes to their positions in OPCH. UMB Bank n.a. increased its stake in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after acquiring an additional 750 shares during the last quarter. GAMMA Investing LLC raised its holdings in Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares during the period. Park Place Capital Corp lifted its position in Option Care Health by 48.4% in the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after buying an additional 372 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after buying an additional 1,446 shares during the period. Finally, Blue Trust Inc. boosted its stake in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after buying an additional 377 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.